Detailed Information for C00839

Basic information about inhibitors

IPAD-DB ID C00839
Name Triptolide
Category Natural compounds
2D Structure
3D Structure
Molecular Formula C 2 0 H 2 4 O 6
Molecular Weight 360.4 g/mol
IUPAC Name (1S, 2S, 4S, 5S, 7R, 8R, 9S, 11S, 13S)-8-hydroxy-1-methyl-7-propan-2-yl-3, 6, 10, 16-tetraoxaheptacyclo[11.7.0.02, 4.02, 9.05, 7.09, 11.014, 18]icos-14(18)-en-17-one
InChI InChI=1S/C20H24O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20, 24-12)16(18)22/h8, 11-14, 16, 22H, 4-7H2, 1-3H3/t11-, 12-, 13-, 14-, 16+, 17-, 18-, 19+, 20+/m0/s1
InChIKey DFBIRQPKNDILPW-CIVMWXNOSA-N
Canonical SMILES CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C
PubChem CID -
DrugBank Accession Number -
CAS Registry Number 38748-32-2

Biological activity data

Ki -
EC50 -
IC50 -
Inhibition -
Toxicity -
ROS(reactive oxygen species) -
Metal Chelating -
BBB(blood-brain barrier) -
Target Protein Aβ25-35
Effects Protect PC12 cells against Aβ25–35-induced cytotoxicity
Research Models In PC12 cells
Main Source Tripterygium wilfordii Hook.f.
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 360.4
Hac(Computed by SwissADME) 26
Volume(Computed by ADMETlab 2.0) 342.049
Density(Computed by ADMETlab 2.0) 1.053
nRing(Computed by ADMETlab 2.0) 7
MaxRing(Computed by ADMETlab 2.0) 20
nHet(Computed by ADMETlab 2.0) 6
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 26
Flexibility(Computed by ADMETlab 2.0) 0.038
Stero Centers(Computed by ADMETlab 2.0) 9
LogS(Computed by ADMETlab 2.0) -3.901
LogD(Computed by ADMETlab 2.0) 3.031

ADMET properties

logP(Computed by ADMETlab 2.0) 2.817
TPSA(Computed by SwissADME) 84.12
Hbond Acceptor(Computed by SwissADME) 6
Hbond Donor(Computed by SwissADME) 1
Rotatable Bonds(Computed by SwissADME)

Pharmacokinetics

GI Absorption(Computed by SwissADME) High
BBB(blood-brain barrier) Permeant(Computed by SwissADME) No
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) No
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) No
CYP3A4 Inhibitor(Computed by SwissADME) No
log Kp(Skin Permeation)(Computed by SwissADME) -8.34

Druglikeness

Lipinski(Computed by SwissADME) 0
Ghose(Computed by SwissADME) 0
Veber(Computed by SwissADME) 0
Egan(Computed by SwissADME) 0
Muegge(Computed by SwissADME) 0
Bioavailability Score(Computed by SwissADME) 0.55